For Immediate Release

Patients Needed to Participate in RSD/CRPS Clinical Trial at National Institutes of Health: Clinical Trial for the Treatment of Early CRPS I and II (Complex Regional Pain Syndromes I and II or Reflex Sympathetic Dystrophy and Causalgia)

A collaborative study (NIH Protocol 00-D-0200) involving investigators in the National Institute of Neurological Disorders and Stroke (NINDS), National Institute of Dental and Craniofacial Research (NIDCR), and Rehabilitation Medicine Department at NIH, is being initiated to examine the use of Neurotropin to treat Complex Regional Pain Syndromes I and II (CRPS I and II). These disorders were formerly known as Reflex Sympathetic Dystrophy (RSD) and Causalgia. Neurotropin is a medication that is currently used in Japan to treat RSD and other painful conditions. This initial study will focus on patients who have recently (within the last one year) developed pain in one limb that has been diagnosed as CRPS I or II. Subjects are now being recruited for this outpatient, double blind, placebo-controlled cross-over study. Eligible patients will be reimbursed for travel and other expenses. They will receive medical care at no cost.

A detailed description of the study and information regarding the admission criteria and contacts are available on the following URL.
http://clinicalstudies.info.nih.gov/detail/A_2000-D-0200.html